After a review of evidence, the UK Health Security Agency (HSA) said today that it no longer classifies clade 1a and 1b mpox ...

On August 13, 2024, the Africa Centres for Disease Control and Prevention (Africa CDC) declared the multi-country mpox ...

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

Travel-related cases of clade I mpox have been reported in the United States, but the risk of clade I mpox to the U.S.

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the third meeting of the International Health Regulations (2005) (IHR) Emergency Committee (Committee) ...

Mpox is rapidly spreading in Kabare, South Kivu, as healthcare systems struggle amidst ongoing conflict in eastern DRC ...

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

PESHAWAR: The Khyber Pakhtunkhwa health department has detected two more mpox cases in the provincial capital, taking the ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve ...